Onco Spherix
Biotechnology, 7935 Fawndale Way, Atlanta, Georgia, 30350, United States, 1-10 Employees
Who is ONCOSPHERIX
OncoSpherix, Inc., based in Atlanta, Ga, is a pre-clinical stage oncology drug development company that is advancing a proprietary platform of first-in-class small molecule therapeutics t...
Read More
-
Headquarters: 7935 Fawndale Way, Atlanta, Georgia, 30350, United States
-
Date Founded: 2018
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 7389
Does something look wrong? Fix it. | View contact records from ONCOSPHERIX
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding OncoSpherix
Answer: OncoSpherix's headquarters are located at 7935 Fawndale Way, Atlanta, Georgia, 30350, United States
Answer: OncoSpherix's official website is https://oncospherix.com
Answer: OncoSpherix's revenue is Under $1 Million
Answer: OncoSpherix's SIC: 7389
Answer: OncoSpherix has 1-10 employees
Answer: OncoSpherix is in Biotechnology
Answer: OncoSpherix contact info: Phone number: Website: https://oncospherix.com
Answer: OncoSpherix, Inc., based in Atlanta, Ga, is a pre-clinical stage oncology drug development company that is advancing a proprietary platform of first-in-class small molecule therapeutics that are designed to improve the quality of life and survival for people with many forms of cancer by targeting a common feature of solid tumors: the activation of hypoxia inducible factor-1 (HIF-1). Nearly all solid cancers grow faster than their blood supply, leading to regions of low oxygen in the tumors and HIF activation. The HIFs in turn induce the expression of over 100 genes that help tumor cells survive and spread. OncoSpherix has several classes of small molecules that block activation of HIF-1 through novel mechanisms. OncoSpherixs lead clinical candiate has been shown in mouse models to reduce primary tumor growth, inhibit metastases, and prolong survival in many types of cancer (glioblastoma, pancreatic cancer, uveal melanoma, lung cancer, breast cancer). Importantly, the agents are well tolerated and can be combined with therapeutics that work in well oxygenated regions of cancers, leading to dramatically enhanced cancer control.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month